<DOC>
	<DOCNO>NCT01094574</DOCNO>
	<brief_summary>Previous study show beta-adrenergic system play role processing pain expression hyperalgesia . Recent study investigate analgesic effect , potential anti-hyperalgesic effect ( use model opioid induce ( OIH ) hyperalgesia ) propranolol , beta adrenergic antagonist . We plan investigate analgesic effect , potential anti inflammatory effect , propranolol compare effect alfentanil , opioid know effect , placebo</brief_summary>
	<brief_title>Evaluation Propranolol 's Effect Pain Inflammation .</brief_title>
	<detailed_description>This study double blind-placebo control study subject expose propranolol infusion one study day , opioid alfentanil another day , placebo infusion third study day . The infusion order randomize , participant individual conducting pain test blind treatment . Propranolol , alfentanil , placebo infusion administer intravenously use computer-controlled infusion pump set accurately administer target plasma concentration drug . On one study day subject receive propranolol target concentration 30ng/ml 3 hour time . On another study day subject receive 100ng/ml alfentanil 3 hour , third study day subject receive placebo ( normal saline ) use computer-controlled infusion paradigm . Sites evaluate response propranolol placebo establish 2 way . One use ultraviolet B ( UVB ) exposure create `` sunburn '' cause inflammation pain . The model acute injury use array micro-needles . Means evaluation injure , non-injured site pain test ( heat mechanical pain threshold establish ) , interstitial fluid sample detection pro-inflammatory , pro-nociceptive cytokine , laser doppler evaluation tissue perfusion . Subjects recruit use flyer . Interested participant contact study team , question answer , appointment screening make .</detailed_description>
	<mesh_term>Propranolol</mesh_term>
	<mesh_term>Adrenergic Antagonists</mesh_term>
	<mesh_term>Alfentanil</mesh_term>
	<criteria>1 ) Age 1865 2 ) Skin type IIIV accord classification Fitzpatrick 3 ) Willing able sign inform consent form Health Insurance Portability Accountability Act ( HIPAA ) authorization comply study procedures 1 ) History acute chronic illness contraindicate use propranolol , may hinder study procedure , confuse interpretation data ( e.g . cardiac , dermatological , neurological , psychiatric addictive disease ) 2 ) Clinically significant cardiovascular , pulmonary , hepatic renal disease 3 ) Pregnant breastfeed 4 ) Intake prescription drug anti/proinflammatory action 5 ) Intake prescription drug anti/proanalgesic action 6 ) Inability abstain anti/proinflammatory , analgesic drug 48 hour , study session 7 ) Inability obtain least 6 hour sleep night precede study session 8 ) Known sensitivity allergy propranolol alfentanil 9 ) Any history drug alcohol abuse</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>